Telix Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	783.21	502.55	160.1	7.6	5.21	Upgrade
Revenue Growth (YoY)	55.85%	213.90%	2007.64%	45.71%	49.58%	Upgrade
Cost of Revenue	299.26	198.03	65.17	2.55	2.02	Upgrade
Gross Profit	483.95	304.52	94.93	5.05	3.19	Upgrade
Selling, General & Admin	207.13	124.29	87.1	46.99	24.48	Upgrade
Research & Development	194.64	128.54	81.01	34.14	23.09	Upgrade
Other Operating Expenses	0.29	-0.19	0.93	-	-	Upgrade
Operating Expenses	402.05	252.63	169.03	86.3	52.44	Upgrade
Operating Income	81.9	51.89	-74.11	-81.25	-49.25	Upgrade
Interest Expense	-7.25	-0.78	-0.32	-0.16	-0.19	Upgrade
Interest & Investment Income	10.86	1.02	0	-	0.07	Upgrade
Currency Exchange Gain (Loss)	18.71	-0.97	-1.12	1.7	-3.94	Upgrade
Other Non Operating Income (Expenses)	-29.69	-12.99	-6.37	14.1	12.11	Upgrade
EBT Excluding Unusual Items	74.53	38.17	-81.92	-65.61	-41.21	Upgrade
Merger & Restructuring Charges	-8.18	-	-	-	-	Upgrade
Asset Writedown	0.77	-0.8	-	-	-	Upgrade
Other Unusual Items	-11.06	-34.28	-16.71	-14.86	-6.73	Upgrade
Pretax Income	56.06	3.09	-98.62	-80.47	-47.94	Upgrade
Income Tax Expense	6.14	-2.12	5.46	0.05	-3.05	Upgrade
Net Income	49.92	5.21	-104.08	-80.51	-44.89	Upgrade
Net Income to Common	49.92	5.21	-104.08	-80.51	-44.89	Upgrade
Net Income Growth	857.95%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	331	319	311	282	257	Upgrade
Shares Outstanding (Diluted)	345	324	311	282	257	Upgrade
Shares Change (YoY)	6.64%	4.21%	10.08%	9.69%	10.21%	Upgrade
EPS (Basic)	0.15	0.02	-0.34	-0.29	-0.17	Upgrade
EPS (Diluted)	0.14	0.02	-0.34	-0.29	-0.17	Upgrade
EPS Growth	798.14%	-	-	-	-	Upgrade
Free Cash Flow	14.25	14.21	-71.01	-60.67	1.71	Upgrade
Free Cash Flow Per Share	0.04	0.04	-0.23	-0.21	0.01	Upgrade
Gross Margin	61.79%	60.60%	59.29%	66.46%	61.17%	Upgrade
Operating Margin	10.46%	10.32%	-46.29%	-1069.60%	-944.81%	Upgrade
Profit Margin	6.37%	1.04%	-65.01%	-1059.90%	-861.06%	Upgrade
Free Cash Flow Margin	1.82%	2.83%	-44.35%	-798.67%	32.84%	Upgrade
EBITDA	87.58	57.17	-69.59	-76.73	-44.94	Upgrade
EBITDA Margin	11.18%	11.38%	-43.47%	-	-	Upgrade
D&A For EBITDA	5.69	5.29	4.52	4.52	4.31	Upgrade
EBIT	81.9	51.89	-74.11	-81.25	-49.25	Upgrade
EBIT Margin	10.46%	10.32%	-46.29%	-	-	Upgrade
Effective Tax Rate	10.95%	-	-	-	-	Upgrade

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q